Back to Home
Released: July 29, 2021 | Expiration: July 28, 2022

Dealing With Itchy Eyes: Recognition and Management of Ocular Pruritus

In this episode, Fidelia Bernice, PharmD, and Aadia I. Rana, MD, share insights on HIV ART safety and tolerability including recent data on nephrotoxicity and the use of NRTI-sparing regimens with discussion of the GEMINI-1 and -2 studies of DTG/3TC and the SWORD-1 and -2 studies of DTG/RPV, and safety with long-acting injectables with specific discussion of the ATLAS and FLAIR studies

Ursula Matulonis, MD

Program Director

Robert L. Coleman, MD, FACOG,

FACS

CME Activities Required : 3

Claim Credit

Claim your credit
Credits Available for this Module

Physician – AMA - 11 Credit(s)

Advanced Practice Nurse – ANCC - 11 Credit(s)

Physician assistant – AAPA - 2.50 Hour(s)

Nurse – ANCC 1 Credit(s)

All the CME Activities for this module has been completed. Please proceed to submit the evaluation.
START EVALUATION

CONGRATULATIONS

you have complete the course and earn a new certificate. Please visit your profile page to view and print your certificate
VIEW CERTIFICATE

Pretest

Step

1 2 3 4
Course Completed
A passing score of 50% or greater is required to obtain credit, please note that the first 2 questions are required, but not graded.

To receive continuing education credit, submit your post-test answers no later than the expiration of this activity. Select the 1 best answer to each question. When you have completed all the questions, press the “Continue” button at the bottom.

01. How often do you advise patients to keep a diary recording possible triggers for their itchy eyes?
02. Once you have identified allergic conjunctivitis, if allergen avoidance and lubricant drops are inadequate, how often do you suggest dual-activity eye drops?
03. Which of the following is true of patients with allergic conjunctivitis?
04. Which of the following topical ophthalmic treatments are available over the counter?
Next